SK Bioscience Co (XKRX:302440) Days Sales Outstanding : 45.91 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is SK Bioscience Co Days Sales Outstanding?

SK Bioscience Co's average Accounts Receivable for the three months ended in Mar. 2024 was ₩11,204 Mil. SK Bioscience Co's Revenue for the three months ended in Mar. 2024 was ₩22,271 Mil. Hence, SK Bioscience Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 45.91.

The historical rank and industry rank for SK Bioscience Co's Days Sales Outstanding or its related term are showing as below:

XKRX:302440' s Days Sales Outstanding Range Over the Past 10 Years
Min: 13.46 Med: 40.87 Max: 157.42
Current: 31.84

During the past 6 years, SK Bioscience Co's highest Days Sales Outstanding was 157.42. The lowest was 13.46. And the median was 40.87.

XKRX:302440's Days Sales Outstanding is ranked better than
84.57% of 888 companies
in the Biotechnology industry
Industry Median: 72.34 vs XKRX:302440: 31.84

SK Bioscience Co's Days Sales Outstanding declined from Mar. 2023 (161.92) to Mar. 2024 (45.91).

SK Bioscience Co Days Sales Outstanding Historical Data

The historical data trend for SK Bioscience Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Bioscience Co Days Sales Outstanding Chart

SK Bioscience Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

74.51

50.74

13.46

31.00

25.94

SK Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															161.92	129.81	20.86	38.82	45.91

Competitive Comparison of SK Bioscience Co's Days Sales Outstanding

For the Biotechnology subindustry, SK Bioscience Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SK Bioscience Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SK Bioscience Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where SK Bioscience Co's Days Sales Outstanding falls into.

SK Bioscience Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

SK Bioscience Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (39584.943	+	12928.077)	/	2 )	/	369505.556	*	365
=	26256.51					/	369505.556	*	365
=	25.94

SK Bioscience Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (12928.077	+	9479.335)	/	2 )	/	22270.678	*	365 / 4
=	11203.706					/	22270.678	*	365 / 4
=	45.91

SK Bioscience Co (XKRX:302440) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

SK Bioscience Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of SK Bioscience Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

SK Bioscience Co (XKRX:302440) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494

Website

https://www.skbioscience.co.kr

SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.

SK Bioscience Co (XKRX:302440) Headlines

No Headlines